Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma

  • Jeter J
  • Bonner J
  • Johnson T
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Because nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit tumor growth in vitro , we investigated the association between NSAIDs and melanoma to determine if there was epidemiologic evidence of a chemopreventive effect from these medications. Three hundred twenty-seven subjects with incident melanoma and 119 melanoma-free controls completed a structured interview assessing melanoma risk factors. The unadjusted odds ratio (OR) for use of nonaspirin NSAIDs was 0.58 (95% CI 0.31–1.11), in a comparison of subjects with melanoma to controls. After adjustment for melanoma risk factors, the OR was 0.71 (95% CI 0.23–2.02). Aspirin users had an unadjusted OR of 0.85 (95% CI 0.45–1.69) and an adjusted OR of 1.45 (95% CI 0.44–4.74). In this pilot study, we found no evidence of a significant association between analgesic use and melanoma risk when potential confounders are assessed. Based on conflicting reports in the literature, meta-analysis may be appropriate.

Cite

CITATION STYLE

APA

Jeter, J. M., Bonner, J. D., Johnson, T. M., & Gruber, S. B. (2011). Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma. Journal of Skin Cancer, 2011, 1–4. https://doi.org/10.1155/2011/598571

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free